What are Mission Vision & Core Values of Teva Pharmaceutical Industries Company?

This element highlights Teva's dual focus. They aim to be a leader in both the affordable generics market and the more complex and innovative biopharmaceutical sector. This strategic balance allows them to address a broad range of healthcare needs.

This emphasizes the ultimate goal: to positively impact the health and well-being of individuals. It underscores Teva's commitment to patient-centricity, which is a core tenet of Pharmaceutical Company Values. This focus drives their research, development, and access-to-medicine initiatives.

This signifies their commitment to a global reach, aiming to provide medicines and healthcare solutions to patients worldwide. This global perspective influences their market strategies, supply chain management, and corporate social responsibility efforts.

The mission statement is inherently customer-centric, with 'patients' at its core. This patient-focused approach is reflected in their research and development of new treatments and their efforts to ensure access to affordable medicines. Moreover, it is a critical aspect in their Marketing Strategy of Teva Pharmaceutical Industries.

The inclusion of biopharmaceuticals highlights Teva's commitment to innovation. This area requires significant investment in research and development, reflecting their strategic goals for the future and their approach to innovation.

Teva's extensive portfolio of generic medicines has contributed significantly to healthcare savings globally. In 2023, Teva's generic medicines sales were approximately $11.8 billion, demonstrating their impact on affordability. Their specialty medicines like AUSTEDO, AJOVY, and UZEDY demonstrate their commitment to improving the lives of patients with specific conditions. Furthermore, their access to medicine programs have provided millions of donated and low-cost doses, directly exemplifying their mission to make quality medicines accessible globally. For instance, in 2023, Teva provided over 12 million doses of essential medicines through its access programs.

Teva's vision is clearly future-oriented, aiming to be a leading force in the pharmaceutical industry. It's about anticipating and shaping the future of healthcare.

The vision encompasses a global scope, seeking to impact healthcare worldwide. Teva aims to make a difference in the lives of patients across the globe.

The vision appears realistic yet aspirational, building upon their established position as a major generics provider. It also strives for leadership in specialty and innovative medicines.

Their 'Pivot to Growth' strategy, which entered its acceleration phase in 2025, aligns with this vision. This focuses on expanding their innovative and biosimilar pipeline and strengthening their generics business.

The goal to build a greater than $5 billion innovative medicines franchise by 2030, led by key products like AUSTEDO, AJOVY, and UZEDY, demonstrates the aspirational aspect of their vision.

Teva's vision emphasizes the delivery of innovative healthcare solutions. This includes a commitment to research and development to meet unmet medical needs.

Teva's strategic decisions are directly influenced by its mission and vision, particularly in its ambitious goals for its innovative pipeline. The company aims to exceed $5 billion in revenue from innovative medicines by 2030, a clear demonstration of its vision to deliver innovative healthcare solutions.

Teva's continued investment in its generics business, with the goal of maintaining a top 3 global portfolio, aligns with its mission of being a global leader in generics and providing affordable medicines. This commitment ensures accessibility to essential medications worldwide.

Teva's financial performance provides tangible evidence of the alignment between its mission, vision, and strategic execution. The company reported nine consecutive quarters of revenue growth as of Q1 2025, fueled by both innovative products and the generics business.

In 2024, Teva's revenues reached $16.5 billion, with significant contributions from both generics and key innovative products. This financial success underscores the company's ability to execute its strategy and achieve its goals.

Teva's access to medicines programs, which have reached hundreds of thousands of patients with millions of doses, directly demonstrate the mission's focus on improving lives globally. This commitment to patient health is a core component of Teva's identity.

Leadership explicitly connects the sustainability strategy, 'Healthy Future,' to their purpose, stating, 'we are all in for better health.' This shows how the core purpose influences broader corporate initiatives beyond just product development. This demonstrates how the company’s Teva Pharmaceutical mission extends into corporate social responsibility.

The 'Pivot to Growth' strategy is a central pillar in implementing Teva's mission. This strategy aims to balance the development and commercialization of both innovative and generic medicines. In 2024, Teva allocated approximately $1.5 billion to research and development, highlighting its dedication to innovation and delivering value to patients. This investment is a clear example of how Teva's vision of delivering innovative solutions is put into practice.

Leadership plays a vital role in reinforcing the mission and values of Teva. CEO Richard Francis has been instrumental in communicating the 'Pivot to Growth' strategy and its alignment with the company's core purpose of 'better health.' This top-down approach ensures that the strategic direction is consistently communicated and understood throughout the organization, fostering a culture that supports Teva's mission and Teva Pharmaceutical mission.

Teva utilizes multiple communication channels to disseminate its mission, vision, and core values. These include its official website, annual reports such as the 'Healthy Future Report,' and internal communication and training programs. These channels are crucial for transparency and for ensuring that all stakeholders, including employees, investors, and the public, are well-informed about Teva's guiding principles and strategic direction. This approach helps to reinforce Teva's core values.

Teva's commitment to its core values is demonstrated through concrete actions. Programs that provide access to medicines exemplify the 'Caring' value and the mission of improving lives globally. Environmental responsibility, such as reducing greenhouse gas emissions and evaluating supplier sustainability, aligns with the 'Healthy Future' purpose. Furthermore, compliance and ethics training for employees reflect the 'Making our families proud' value, ensuring ethical conduct.